Total Assets Summary of Gilead Sciences, Inc.

Gilead Sciences, Inc.'s latest annual total assets in 2023 was 62.12 Billion USD , down -1.66% from previous year.
Gilead Sciences, Inc.'s latest quarterly total assets in 2024 Q1 was 56.29 Billion USD , down -9.39% from previous quarter.
Gilead Sciences, Inc. reported annual total assets of 63.17 Billion USD in 2022, down -7.04% from previous year.
Gilead Sciences, Inc. reported annual total assets of 67.95 Billion USD in 2021, down -0.67% from previous year.
Gilead Sciences, Inc. reported quarterly total assets of 53.57 Billion USD for 2024 Q2, down -4.82% from previous quarter.
Gilead Sciences, Inc. reported quarterly total assets of 62.12 Billion USD for 2023 FY, down -1.66% from previous quarter.

Annual Total Assets Chart of Gilead Sciences, Inc. (2023 - 1990)

Historical Annual Total Assets of Gilead Sciences, Inc. (2023 - 1990)

Year	Total Assets	Total Assets Growth
2023	62.12 Billion USD	-1.66%
2022	63.17 Billion USD	-7.04%
2021	67.95 Billion USD	-0.67%
2020	68.4 Billion USD	11.0%
2019	61.62 Billion USD	-3.22%
2018	63.67 Billion USD	-9.4%
2017	70.28 Billion USD	23.35%
2016	56.97 Billion USD	9.91%
2015	51.83 Billion USD	49.55%
2014	34.66 Billion USD	54.08%
2013	22.49 Billion USD	5.92%
2012	21.23 Billion USD	22.75%
2011	17.3 Billion USD	49.26%
2010	11.59 Billion USD	19.53%
2009	9.69 Billion USD	38.18%
2008	7.01 Billion USD	20.29%
2007	5.83 Billion USD	42.8%
2006	4.08 Billion USD	8.54%
2005	3.76 Billion USD	74.62%
2004	2.15 Billion USD	38.67%
2003	1.55 Billion USD	20.69%
2002	1.28 Billion USD	62.08%
2001	794.78 Million USD	17.21%
2000	678.09 Million USD	55.24%
1999	436.8 Million USD	44.21%
1998	302.9 Million USD	-13.97%
1997	352.1 Million USD	13.32%
1996	310.7 Million USD	86.38%
1995	166.7 Million USD	31.67%
1994	126.6 Million USD	0.0%
1992	146.8 Million USD	35.05%
1991	108.7 Million USD	769.6%
1990	12.5 Million USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	56.29 Billion USD	-9.39%
2024 Q2	53.57 Billion USD	-4.82%
2023 FY	62.12 Billion USD	-1.66%
2023 Q1	61.87 Billion USD	-2.05%
2023 Q3	62.37 Billion USD	0.06%
2023 Q2	62.33 Billion USD	0.75%
2023 Q4	62.12 Billion USD	-0.4%
2022 Q1	63.08 Billion USD	-7.17%
2022 Q3	62.55 Billion USD	-0.5%
2022 FY	63.17 Billion USD	-7.04%
2022 Q2	62.87 Billion USD	-0.33%
2022 Q4	63.17 Billion USD	0.98%
2021 Q1	67.49 Billion USD	-1.34%
2021 Q2	67.98 Billion USD	0.73%
2021 Q3	67.09 Billion USD	-1.3%
2021 Q4	67.95 Billion USD	1.27%
2021 FY	67.95 Billion USD	-0.67%
2020 Q3	60.87 Billion USD	8.84%
2020 Q2	55.93 Billion USD	-6.37%
2020 FY	68.4 Billion USD	11.0%
2020 Q1	59.74 Billion USD	-3.06%
2020 Q4	68.4 Billion USD	12.37%
2019 Q1	62.83 Billion USD	-1.32%
2019 Q3	59.14 Billion USD	-6.43%
2019 Q2	63.21 Billion USD	0.59%
2019 FY	61.62 Billion USD	-3.22%
2019 Q4	61.62 Billion USD	4.19%
2018 Q3	64.3 Billion USD	-1.61%
2018 Q2	65.35 Billion USD	-0.04%
2018 Q4	63.67 Billion USD	-0.98%
2018 Q1	65.38 Billion USD	-6.97%
2018 FY	63.67 Billion USD	-9.4%
2017 FY	70.28 Billion USD	23.35%
2017 Q4	70.28 Billion USD	8.69%
2017 Q3	64.66 Billion USD	7.3%
2017 Q2	60.26 Billion USD	4.44%
2017 Q1	57.7 Billion USD	1.27%
2016 Q3	56.6 Billion USD	13.26%
2016 Q1	47.76 Billion USD	-7.86%
2016 Q2	49.98 Billion USD	4.64%
2016 Q4	56.97 Billion USD	0.65%
2016 FY	56.97 Billion USD	9.91%
2015 Q2	39.16 Billion USD	2.21%
2015 Q4	51.83 Billion USD	2.37%
2015 FY	51.83 Billion USD	49.55%
2015 Q3	50.63 Billion USD	29.28%
2015 Q1	38.32 Billion USD	10.55%
2014 Q4	34.66 Billion USD	20.18%
2014 Q3	28.84 Billion USD	-7.57%
2014 Q2	31.2 Billion USD	11.14%
2014 FY	34.66 Billion USD	54.08%
2014 Q1	28.07 Billion USD	24.81%
2013 Q4	22.49 Billion USD	0.13%
2013 Q3	22.46 Billion USD	-0.69%
2013 FY	22.49 Billion USD	5.92%
2013 Q1	22.21 Billion USD	4.58%
2013 Q2	22.62 Billion USD	1.86%
2012 Q2	20.5 Billion USD	2.76%
2012 FY	21.23 Billion USD	22.75%
2012 Q4	21.23 Billion USD	1.32%
2012 Q3	20.96 Billion USD	2.25%
2012 Q1	19.95 Billion USD	15.3%
2011 FY	17.3 Billion USD	49.26%
2011 Q4	17.3 Billion USD	36.89%
2011 Q3	12.63 Billion USD	-0.43%
2011 Q2	12.69 Billion USD	-2.26%
2011 Q1	12.98 Billion USD	12.03%
2010 Q4	11.59 Billion USD	1.2%
2010 Q1	10.69 Billion USD	10.28%
2010 FY	11.59 Billion USD	19.53%
2010 Q2	10.49 Billion USD	-1.86%
2010 Q3	11.45 Billion USD	9.14%
2009 Q3	8.93 Billion USD	6.56%
2009 Q1	7.51 Billion USD	7.14%
2009 Q4	9.69 Billion USD	8.52%
2009 FY	9.69 Billion USD	38.18%
2009 Q2	8.38 Billion USD	11.53%
2008 Q2	6.51 Billion USD	10.86%
2008 Q1	5.87 Billion USD	0.76%
2008 Q4	7.01 Billion USD	0.64%
2008 Q3	6.97 Billion USD	7.01%
2008 FY	7.01 Billion USD	20.29%
2007 FY	5.83 Billion USD	42.8%
2007 Q3	5.31 Billion USD	10.19%
2007 Q1	4.61 Billion USD	12.96%
2007 Q2	4.82 Billion USD	4.56%
2007 Q4	5.83 Billion USD	9.73%
2006 Q3	5.29 Billion USD	2.31%
2006 Q2	5.17 Billion USD	28.32%
2006 Q4	4.08 Billion USD	-22.89%
2006 Q1	4.03 Billion USD	7.22%
2006 FY	4.08 Billion USD	8.54%
2005 FY	3.76 Billion USD	74.62%
2005 Q4	3.76 Billion USD	28.98%
2005 Q3	2.91 Billion USD	8.58%
2005 Q2	2.68 Billion USD	13.45%
2005 Q1	2.36 Billion USD	9.9%
2004 Q3	1.98 Billion USD	9.8%
2004 Q2	1.8 Billion USD	7.93%
2004 Q1	1.67 Billion USD	7.77%
2004 FY	2.15 Billion USD	38.67%
2004 Q4	2.15 Billion USD	8.58%
2003 FY	1.55 Billion USD	20.69%
2003 Q4	1.55 Billion USD	33.09%
2003 Q3	1.16 Billion USD	8.68%
2003 Q2	1.07 Billion USD	14.01%
2003 Q1	942.77 Million USD	-26.81%
2002 Q1	787.73 Million USD	-0.89%
2002 Q4	1.28 Billion USD	47.01%
2002 Q3	876.22 Million USD	7.38%
2002 Q2	815.97 Million USD	3.58%
2002 FY	1.28 Billion USD	62.08%
2001 Q3	632.93 Million USD	-0.59%
2001 Q1	657.54 Million USD	-3.03%
2001 FY	794.78 Million USD	17.21%
2001 Q4	794.78 Million USD	25.57%
2001 Q2	636.66 Million USD	-3.18%
2000 Q4	678.09 Million USD	55.56%
2000 Q2	436.53 Million USD	0.51%
2000 Q1	434.32 Million USD	-0.57%
2000 FY	678.09 Million USD	55.24%
2000 Q3	435.91 Million USD	-0.14%
1999 Q3	449.2 Million USD	65.09%
1999 Q2	272.1 Million USD	-5.72%
1999 Q4	436.8 Million USD	-2.76%
1999 Q1	288.6 Million USD	-4.72%
1999 FY	436.8 Million USD	44.21%
1998 Q3	316.7 Million USD	-4.98%
1998 Q2	333.3 Million USD	-4.61%
1998 FY	302.9 Million USD	-13.97%
1998 Q4	302.9 Million USD	-4.36%
1998 Q1	349.4 Million USD	-0.77%
1997 Q2	354 Million USD	13.32%
1997 Q1	312.4 Million USD	0.55%
1997 FY	352.1 Million USD	13.32%
1997 Q3	348.2 Million USD	-1.64%
1997 Q4	352.1 Million USD	1.12%
1996 Q3	315.4 Million USD	3.75%
1996 Q4	310.7 Million USD	-1.49%
1996 Q2	304 Million USD	-3.61%
1996 Q1	315.4 Million USD	0.0%
1996 FY	310.7 Million USD	86.38%
1995 Q3	176 Million USD	87.63%
1995 Q1	102.4 Million USD	-7.83%
1995 Q2	93.8 Million USD	-8.4%
1995 FY	166.7 Million USD	31.67%
1994 Q1	126.6 Million USD	-5.45%
1994 FY	126.6 Million USD	0.0%
1994 Q4	111.1 Million USD	-6.8%
1994 Q3	119.2 Million USD	-3.56%
1994 Q2	123.6 Million USD	-2.37%
1993 Q1	146.8 Million USD	1.38%
1993 Q2	141.6 Million USD	-3.54%
1993 Q3	139.8 Million USD	-1.27%
1993 Q4	133.9 Million USD	-4.22%
1992 Q1	108.7 Million USD	0.0%
1992 Q3	107.1 Million USD	0.47%
1992 FY	146.8 Million USD	35.05%
1992 Q4	144.8 Million USD	35.2%
1992 Q2	106.6 Million USD	-1.93%
1991 Q1	12.5 Million USD	0.0%
1991 FY	108.7 Million USD	769.6%
1990 FY	12.5 Million USD	0.0%

Peer Total Assets Comparison of Gilead Sciences, Inc.

Name	Total Assets	Total Assets Difference
Amgen Inc.	97.15 Billion USD	36.055%
AstraZeneca PLC	101.11 Billion USD	38.562%
Biogen Inc.	26.84 Billion USD	-131.423%
MIRA Pharmaceuticals, Inc.	4.93 Million USD	-1259417.849%
Scilex Holding Company	101.3 Million USD	-61222.291%
Scilex Holding Company	101.3 Million USD	-61222.291%

Global Stocks Search

Gilead Sciences, Inc. (GILD)

Total Assets Summary of Gilead Sciences, Inc.

Annual Total Assets Chart of Gilead Sciences, Inc. (2023 - 1990)

Historical Annual Total Assets of Gilead Sciences, Inc. (2023 - 1990)

Peer Total Assets Comparison of Gilead Sciences, Inc.